Company intelligence / Profile preview

CureBridge Collaborative

Kansas City or Lawrence, Kansas, United Statesdot.nd.gov ↗

Ownership: Private
Development stage: Other

Overview

CureBridge Collaborative is a public-private partnership that enables early-stage development and commercialization of biotech innovations. It organizes and supports new biotech companies—staffed by industry experts and funded through SBIR/STTR grants—often in collaboration with the University of Kansas Medical Center and Institute for Advancing Medical Innovation. Its spinouts are developing technologies ranging from olfactory diagnostics for neurological diseases to drug delivery systems for cancer, with some programs advancing into clinical trials.

Therapeutic areas: PsychiatryNeurologyOncology
Modalities: Small moleculeDiagnostic technology
Industry: Investors

Partnerships

University of Kansas Medical CenterInstitute for Advancing Medical InnovationBioNovusMRIGlobalUniversity of Florida (for Ergot Biosciences)

Beyond the preview

Go deeper on CureBridge Collaborative.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CureBridge Collaborative.

Explore the full profile